TFPI and gram-negative bacterial infections: Several reports have demonstrated that TFPI can be used in the treatment of Gram-negative bacterial infections, suggesting a therapeutic strategy targeting the coagulation pathway [100–102], and nebulized or injected recombinant human TFPI has been reported to mitigate both pulmonary and systemic coagulation [103, 104].